The Korean Journal of Nuclear Medicine (대한핵의학회지)
- Volume 29 Issue 1
- /
- Pages.54-60
- /
- 1995
- /
- 1225-6714(pISSN)
Absorbed Dose Measurement by the MIRD System in the $^{131}I$ Treated Thyroid Cancer Patients
갑상선 암 환자에서 $^{131}I$ 치료시 MIRD Schema에 의한 흡수선량의 평가
- Lim, Sang-Moo (Department of Nuclear Medicine, Korea Cancer Center Hospital) ;
- Woo, Kwang-Sun (Department of Nuclear Medicine, Korea Cancer Center Hospital) ;
- Chung, Wee-Sup (Department of Nuclear Medicine, Korea Cancer Center Hospital) ;
- Hong, Sang-Woon (Department of Nuclear Medicine, Korea Cancer Center Hospital) ;
- Kim, Jang-Hee (Laboratory of Radiation Safety and Control) ;
- Kim, Ki-Sup (Laboratory of Radiation Safety and Control)
- 임상무 (원자력병원 핵의학과) ;
- 우광선 (원자력병원 핵의학과) ;
- 정위섭 (원자력병원 핵의학과) ;
- 홍성운 (원자력병원 핵의학과) ;
- 김장휘 (방사선보건관리실) ;
- 김기섭 (방사선보건관리실)
- Published : 1995.03.31
Abstract
Medical Internal Radiation Dose(MIRD) schema was developed for calculating the absorbed dose from the administered radiopharmaceuticals. With the biological distribution data and the physical properties of the radionuclide we can estimate the absorbed dose by the MIRD schema. For the thyroid cancer patients received
방사성 핵종의 체내 투여 또는 체내 오염에 의한 내부피폭 흡수선량 측정을 위하여 개발된 MIRD 씨스템을 이용하여 175mCi